Heptan-3-yl 2-cyanoprop-2-enoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Heptan-3-yl 2-cyanoprop-2-enoate
• 英文别名: heptan-3-yl 2-cyanoprop-2-enoate
• 化学式: C₁₁H₁₇NO₂
• 分子量: 195.26
• InChiKey: FIRBSSWDIDNKQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  50.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Composition, reaction product, kit and applicator, especially for use in medicine
  申请人：AESCULAP AG

  公开号：EP2708245A2

  公开（公告）日：2014-03-19

  The invention relates to a composition, especially for use in medicine, comprising a component a) containing cyanoacrylate monomers and an aqueous component b), wherein the composition further comprises an acid and a salt which reacts with the acid to release a gas. The invention further relates to a reaction product obtainable from the composition in the form of a porous and specifically shape-stable foamed structure in particular. The invention further relates to a kit comprising spatially separate from each other an acid component a) and a salt component b) and also to an applicator having a first chamber containing an acid component a) and a second chamber containing a salt component b).

  本发明涉及一种组合物，特别是用于医药的组合物，该组合物包括含有氰基丙烯酸酯单体的成分 a) 和含水成分 b)，其中该组合物还包括一种酸和一种盐，该盐与酸反应释放出一种气体。 本发明还涉及一种可从该组合物中获得的反应产物，其形式尤其为多孔且形状稳定的发泡结构。 本发明还涉及一种试剂盒，该试剂盒包括在空间上相互分离的酸组分 a) 和盐组分 b)，还涉及一种涂抹器，该涂抹器具有一个装有酸组分 a) 的第一腔室和一个装有盐组分 b) 的第二腔室。
• COMPOSITION, REACTION PRODUCT, KIT AND APPLICATOR, ESPECIALLY FOR USE IN MEDICINE
  申请人：AESCULAP AG

  公开号：EP2708245B1

  公开（公告）日：2019-03-20
• NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS
  申请人：SINTEF TTO AS

  公开号：US20220160645A1

  公开（公告）日：2022-05-26

  The invention relates to a nanoparticle comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits according to formula 2A, wherein each R 1 is independently selected from the group consisting of 2-ethylhexyl, 2-phenylethyl, neopentyl, 1-pentyl, 2-pentyl, 3-pentyl, 3,3-dimethyl-1-butyl, 3-methylbutyl, -heptyl, 2-heptyl, and 3-heptyl; and wherein the nanoparticle further comprises an active agent. The invention also provides compositions comprising the nanoparticles, and the nanoparticles for use in therapy or diagnosis, such as in the treatment of cancer or an infection, or for use in diagnostic imaging.